Patient-Derived Xenografts and Matched Cell Lines Identify Pharmacogenomic Vulnerabilities in Colorectal Cancer
Luca Lazzari(Vita-Salute San Raffaele University), Sabrina Arena(Candiolo Cancer Institute)
Cited by 77
Related Papers
Emergence of Multiple <i>EGFR</i> Extracellular Mutations during Cetuximab Treatment in Colorectal Cancer
|Clinical Cancer Research|2015|273
Vitamin C Restricts the Emergence of Acquired Resistance to EGFR-Targeted Therapies in Colorectal Cancer
|Cancers|2020|72
Codon bias imposes a targetable limitation on KRAS-driven therapeutic resistance
|Nature Communications|2017|46
Prediction of homologous recombination deficiency identifies colorectal tumors sensitive to PARP inhibition
|npj Precision Oncology|2024|5